Antibiotics Market Demand, Size, Share & Forecast 2032

Antibiotics Market

Antibiotics Market By Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors ), By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, and Others), And By Region - Global Industry Perspective, Size, Trends, Comprehensive Analysis, And Forecast, 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 240 Report Code: ZMR-4064 Published Date: Jun-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 39.44 Billion USD 54.87 Billion 3.86% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Antibiotics Market , 2024–2032(USD Billion)
    • 2.2. Antibiotics Market : Snapshot
  • Chapter 3. Global Antibiotics Market – Industry Analysis
    • 3.1. Antibiotics Market : Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Growing efforts as well as investments made by the key firms in research & development for producing new drugs will prompt the expansion of antibiotics industry over the forecast timespan.
      • 3.2.2. Favorable government laws like generating antibiotics incentives now act is projected to expedite the development of antibiotic treatments against pathogens and this will steer the market growth.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Drug Class
      • 3.4.2. Market attractiveness analysis By Action Mechanism
  • Chapter 4. Global Antibiotics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Antibiotics Market: company market share, 2024
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Antibiotics Market–Drug Class Analysis
    • 5.1. Global Antibiotics Market overview: By Drug Class
      • 5.1.1. Global Antibiotics Market share, By Drug Class,2024 and 2032
    • 5.2. Cephalosporins
      • 5.2.1. Global Antibiotics Market by Cephalosporins , 2024–2032(USD Billion)
    • 5.3. Penicillin
      • 5.3.1. Global Antibiotics Market by Penicillin , 2024–2032(USD Billion)
    • 5.4. Fluoroquinulones
      • 5.4.1. Global Antibiotics Market by Fluoroquinulones , 2024–2032(USD Billion)
  • Chapter 6. Global Antibiotics Market–Action Mechanism Analysis
    • 6.1. Global Antibiotics Market overview: By Action Mechanism
      • 6.1.1. Global Antibiotics Market share, By Action Mechanism , 2024 and 2032
    • 6.2. DNA
      • 6.2.1. Global Antibiotics Market By DNA , 2024–2032(USD Billion)
    • 6.3. Protein
      • 6.3.1. Global Antibiotics Market By Protein, 2024–2032(USD Billion)
    • 6.4. Cell Wall Synthesis Inhibitors
      • 6.4.1. Global Antibiotics Market By Cell Wall Synthesis Inhibitors, 2024–2032(USD Billion)
    • 6.5. RNA
      • 6.5.1. Global Antibiotics Market By RNA, 2024–2032(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Janssen Pharmaceuticals
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Pfizer, Inc.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. GlaxoSmithKline plc
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Abbott Laboratories
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Novartis AG
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Sanofi S.A.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Bristul Myers Squibb Company
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Bayer AG
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Astellas Pharma, Inc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Eli Lilly and Company
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Antibiotics Market, 2024–2032(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Antibiotics Market attractiveness, By Drug Class
6. Global Antibiotics Market attractiveness, By Action Mechanism
7. Global Antibiotics Market share, By Drug Class, 2024 and 2032 (USD Billion)
8. Global Antibiotics Market by Cephalosporins  , 2024–2032(USD Billion)
9. Global Antibiotics Market by Penicillin ,2024–2032(USD Billion)
10. Global Antibiotics Market by Fluoroquinolones,2024–2032(USD Billion)
11. Global Antibiotics Market Share by Action Mechanism ,2024 and 2032 (USD Billion)
12. Global Antibiotics Market by DNA ,2024–2032(USD Billion)
13. Global Antibiotics Market by Protein,2024–2032(USD Billion)
14. Global Antibiotics Market by Cell Wall Synthesis Inhibitors,2024–2032(USD Billion)
15. Global Antibiotics Market by RNA,2024–2032(USD Billion)
16. Global Antibiotics Market share, by Region, 2024 and 2032
17. North America Antibiotics Market, 2024–2032(USD Billion)
18. Europe Antibiotics Market, 2024–2032(USD Billion)
19. Asia Pacific Antibiotics Market, 2024–2032(USD Billion)
20. Latin America Antibiotics Market, 2024–2032(USD Billion)
21. The Middle East and Africa Antibiotics Market, 2024–2032(USD Billion)


Table Of Tables

List of Tables

1. Global Antibiotics Market: snapshot
2. Drivers of the Antibiotics Market: impact analysis
3. North America Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
4. North America Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
5. The U.S. Antibiotics Market revenue, By Drug Class, 2024–2032(USD Billion)
6. The U.S. Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
7. Rest of North America Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
8. Rest of North America Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
9. Europe Antibiotics Market revenue, By Drug Class, 2024–2032(USD Billion)
10. Europe Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
11. UK Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
12. UK Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
13. France Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
14. France Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
15. Germany Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
16. Germany Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
17. Rest of Europe Antibiotics Market revenue, By Action Mechanism,2024–2032(USD Billion)
18. Rest of Europe Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
19. Asia Pacific Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
20. Asia Pacific Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
21. China Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
22. China Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
23. Japan Antibiotics Market revenue, By Drug Class, 2024–2032(USD Billion)
24. Japan Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
25. India Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
26. India Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
27. Rest of Asia Pacific Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
28. Rest of Asia Pacific Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
29. Latin America Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
30. Latin America Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
31. Brazil Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
32. Brazil Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
33. Rest of Latin America Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
34. Rest of Latin America Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
35. The Middle East and Africa Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
36. The Middle East and Africa Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
37. Saudi Arabia Antibiotics Market revenue, By Drug Class, 2024–2032(USD Billion)
38. Saudi Arabia Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
39. South Africa Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
40. South Africa Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)
41. Rest of the Middle East & Africa Antibiotics Market revenue, By Drug Class,2024–2032(USD Billion)
42. Rest of the Middle East & Africa Antibiotics Market revenue, By Action Mechanism , 2024–2032(USD Billion)

 
 

Methodology

FrequentlyAsked Questions

Antibiotics are medicines that fight bacterial infections by killing the bacteria or stopping them from growing.

According to a study, the global antibiotics market size was worth around USD 39.44 billion in 2023 and is expected to reach USD 54.87 billion by 2032.

The global antibiotics market is expected to grow at a CAGR of 3.86% during the forecast period.

Asia Pacific is expected to dominate the antibiotics market over the forecast period.

Leading players in the global antibiotics market include Novartis AG, Bayer AG, Janssen Pharmaceuticals, Astellas Pharma, Inc., Pfizer, Inc., GlaxoSmithKline plc, Bristol Myers Squibb Company, Abbott Laboratories, Sanofi S.A., and Eli Lilly and Company, among others.

The antibiotics market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.

Choose License Type

  • zion payment modes

List of Contents

Industry PerspectiveReport ScopeCompetitive Analysis

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed